CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 504 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01714921
NCT01714921N/ACompleted
CompareCT.gov

ProSA Protecta Smart Analysis Register

Medtronic Cardiac Rhythm and Heart Failure·observational·Posted Oct 26, 2012·Updated Jul 2, 2025

In Brief

An observational study for Patients With an Indication for an ICD Implantation According to the Guidelines. Completed, enrolled 504 participants.

Detailed Summary

ProSA is a prospective, non-randomized, multicenter, observational study investigating the utilization and effectiveness of the Smart Shock™ algorithm in ICD patients treated with a Protecta™, Protecta™ XT or any equivalent following product.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPatients With an Indication for an ICD Implantation According to the Guidelines
Countries--
CollaboratorsMedtronic GmbH Germany

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 26, 2012
Enrollment StartJun 9, 2010
Primary CompletionJan 5, 2015
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 13.7 years ago